Alkermes PLC $44.73

up +0.25


29/8/2014 04:00 PM  |  NASDAQ : ALKS  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get ALKS Trend Analysis - it has outperformed the S&P 500 by 17%

Partner Headlines

  1. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  2. Morgan Stanley Sees EPS Below Consensus, Robust Pipeline For Alkermes plc

    Benzinga
  3. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest Revenue

    Benzinga
  4. Alkermes' drug passes trial

    IBD
  5. Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

    Benzinga
  6. Stocks Rise, Led By Tech Stocks, But Volume Fades

    IBD
  7. Mid-Afternoon Market Update: Markets Recover Slightly as Coal Shows Strength

    Benzinga
  8. Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On Lower Forecast

    Benzinga
  9. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD
  10. Benzinga's Volume Movers

    Benzinga
  11. Mid-Morning Market Update: Markets Mixed; A. Schulman Lifts Profit Outlook

    Benzinga
  12. Morning Market Movers

    Benzinga
  13. Alkermes Announces Positive Topline Results From Pivotal Phase 3 Study ...

    Benzinga
  14. Benzinga's Top Initiations

    Benzinga
  15. Nasdaq Back Above Water; Green Plains Jumps

    IBD
  16. LifeLock, YY Among 5 Stocks With Top Fundamentals

    IBD
  17. Stocks Fall In Higher Volume; Yandex, Twitter Drop

    IBD
  18. Stocks Weaken After Fed Minutes; Thor Rallies

    IBD
  19. Stocks End Short Week With Big Losses

    IBD
  20. Alkermes Announces Advances in Late-Stage CNS Pipeline

    Benzinga
  21. Alkermes Receives Notice of Allowance of US Patent for Novel Fumarate Prodrug ...

    Benzinga
  22. Ireland Home To Several Fast Growing Health Care Names

    IBD
  23. Alkermes Presents Data on Aripiprazole Lauroxil and ALKS 5461 at 52nd Annual ...

    Benzinga
  24. UPDATE: Citigroup Raises PT on Alkermes on Multiple Value Opportunities

    Benzinga
  25. Alkermes, FDA Agree on Deal for Elements of ALKS 5461 Development Program

    Benzinga
  26. Top 4 Stocks In The Drug Delivery Industry With The Highest Cash

    Benzinga
  27. Acceleron Pharma IPO Pops; Fate Therapeutics On Deck

    IBD
  28. Google, LKQ, Tesla: Stocks A Marsico Manager Likes

    IBD
  29. Stocks End Mixed In Light Trade; Green Mountain Spurts Ahead

    IBD
  30. Stocks Down Modestly; Alkermes Ramps Up

    IBD
  31. Alkermes

    IBD
  32. Stocks Up, Google At High; Dow Takes Out 14,000

    IBD
  33. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  34. Alkermes

    IBD
  35. Stocks Slip As Fed Stands Pat; SodaStream Trims Gain

    IBD
  36. Alkermes Trades Tightly, Holds In Buying Range

    IBD
  37. UPDATE: Credit Suisse Initiates Alkermes at Neutral; Looking For Better ...

    Benzinga
  38. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  39. Top 4 Stocks In The Drug Delivery Industry With The Highest EPS Estimates ...

    Benzinga
  40. Stocks Hold Modest Gains; MI Homes Hits Multiyear High

    IBD
  41. Alkermes In Buy Area After Breakout In Strong Volume

    IBD
  42. Stocks Pare Early Losses, End With Modest Declines

    IBD
  43. Alkermes Announces Notice of Allowance of USPTO Application for Aripiprazole ...

    Benzinga
  44. Alkermes Announces Positive Results from Phase 1 Study of ALKS 3831

    Benzinga
  45. Biotech Alkermes Sketches Imperfect Cup With Handle

    IBD
  46. Alkermes' Acquisition Proves To Be Game-Changer

    IBD
  47. Alkermes' Corporate Presentation to be Webcast at Two Upcoming Conferences

    Benzinga
  48. Dow Leads Market Higher As Volume Swells

    IBD
  49. Stocks Add To Gains; DaVita HealthCare Jumps

    IBD
  50. Alkermes Flies As Q2 Results, Guidance Beat Estimates

    IBD
Trading Center